Former Indevus VP Agrees To Insider Trading Deal
A former vice president of Indevus Pharmaceuticals Inc. has agreed to pay the U.S. Securities and Exchange Commission over $130,000 to settle insider trading allegations brought by regulators that accused the...To view the full article, register now.
Already a subscriber? Click here to view full article